Increasing Receipt of High-Tech/High-Cost Imaging and Its Determinants in the Last Month of Taiwanese Patients With Metastatic Cancer, 2001–2010: A Retrospective Cohort Study

One strategy for controlling the skyrocketing costs of cancer care may be to target high-tech/high-cost imaging at the end of life (EOL). This population-based study investigated receipt of high-tech/high-cost imaging and its determinants for Taiwanese patients with metastatic cancer in their last m...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tsang-Wu, Hung, Yen-Ni, Soong, Thomas C., Tang, Siew Tzuh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
6100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616695/
https://www.ncbi.nlm.nih.gov/pubmed/26266390
http://dx.doi.org/10.1097/MD.0000000000001354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616695/
https://www.ncbi.nlm.nih.gov/pubmed/26266390
http://dx.doi.org/10.1097/MD.0000000000001354

Ejemplares similares